Financial Statements · Financial Reporting
Novo Nordisk Estonia OÜ
Official identifier 16722379Record date 31 Dec 2023
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 21 Apr 2023
- Submitted date
- 1 Oct 2024
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 5,191,016 |
| Balance sheet | Cash and cash equivalents | 294,710 |
| Balance sheet | Current assets | 5,191,016 |
| Balance sheet | Current liabilities | 4,728,826 |
| Balance sheet | Equity | 417,418 |
| Balance sheet | Share capital at nominal value | 200,000 |
| Balance sheet | Non-current liabilities | 44,772 |
| Balance sheet | Retained earnings (loss) from previous periods | 0 |
| Income statement scheme 1 | Labour costs | -521,953 |
| Income statement scheme 1 | Revenue | 6,027,246 |
| Income statement scheme 1 | Annual period profit / loss | 217,418 |
| Income statement scheme 1 | Operating profit (loss) | 210,891 |
| Income statement scheme 1 | Profit (loss) before income tax | 217,418 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 0 |
| Kasumi jaotamise otsus | Retained earnings (loss) from previous periods | 0 |
| Note: Labour costs | Employees | 16 |
| Note: Labour costs | Labour costs | 521,953 |
Linked company
Company: Novo Nordisk Estonia OÜ